In another study authors observed that MCI patients, who were followed for almost 5 years, showed a mild to moderate increasing trend for the plasma GFAP, thus making this protein a promising biomarker of conversion from MCI to AD [35]. The gene discussed is GFAP; the disease is Alzheimer disease.